Literature DB >> 15218301

Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytes.

Oren Shibolet1, Ruslana Alper, Lydia Zlotogarov, Barbara Thalenfeld, Dean Engelhardt, Elazar Rabbani, Yaron Ilan.   

Abstract

BACKGROUND: Oral immune regulation towards viral proteins was previously shown to modulate the anti-HBV immune response. Adoptive transfer of orally immunomodulated lymphocytes suppressed the growth of hepatocellular carcinoma (HCC) expressing HBsAg in athymic mice. NKT lymphocytes play a role in the defense against tumor growth. AIM: To evaluate the effect of oral immune regulation towards HCC-associated antigens or HBV proteins on growth of HBsAg-expressing HCC, and to determine the role of NKT lymphocytes in immune modulation.
METHODS: Sublethally irradiated athymic Balb/c mice were injected with 10(7) human hepatoma cells followed 10 days later by transplantation of 2 x 10(6) splenocytes from naive donor mice. Immune modulation was performed via feeding of HCC-extracted proteins or HBV antigens (HBsAg + Pre S1 + Pre S2). The control group was fed with bovine serum albumin (BSA). Mice were followed for survival, tumor volume, and serum alpha-fetoprotein levels. To determine the role of NKT cells in tumor suppression, cytokine expression and FACS analysis for CD4+, CD8+, and NK1.1+ T lymphocyte subsets were performed.
RESULTS: Oral immune regulation towards HCC-extracted proteins induced complete tumor suppression in recipient mice. Mortality rates were 0% in HCC-immune-regulated mice, compared with an 80% mortality rate using HBV antigens and a 100% mortality rate in control mice. Oral immune regulation towards HCC prevented weight loss. No visible tumor mass was observed in orally immune-regulated mice as compared with 112 mm(3) in controls. Serum alphaFP levels were 0.9, 378 and 1,358 ng/ml in HCC, HBV immune-regulated and controls, respectively. Immune regulation towards HCC antigens significantly increased the NK1.1+ T lymphocytes/CD4+ and CD8+/CD4+ ratios. IFNgamma production increased two-fold.
CONCLUSION: Oral immune regulation towards HCC antigens effectively enhanced the anti-tumor immune response, thus suppressing the growth of HCC in mice. This effect was associated with an increased NKT,CD8+/CD4+ lymphocyte ratio and may be mediated via enhancement of IFNgamma production. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15218301     DOI: 10.1159/000078334

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  10 in total

1.  Multiple courses of immunotherapy with different immune cell types for patients with hepatocellular carcinoma after microwave ablation.

Authors:  Ming-An Yu; Ping Liang; Xiao-Ling Yu; Zhi-Yu Han; Xue-Juan Dong; Y U Wang; Chao Cheng; Xin Li
Journal:  Exp Ther Med       Date:  2015-08-14       Impact factor: 2.447

2.  Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn's disease.

Authors:  Eran Israeli; Yaron Ilan
Journal:  Therap Adv Gastroenterol       Date:  2010-01       Impact factor: 4.409

3.  Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease.

Authors:  Cheng-Fu Xu; Chao-Hui Yu; You-Ming Li; Lei Xu; Juan Du; Zhe Shen
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

4.  Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders.

Authors:  E Zigmond; S Preston; O Pappo; G Lalazar; M Margalit; Z Shalev; L Zolotarov; D Friedman; R Alper; Y Ilan
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

5.  Oral mixture of autologous colon-extracted proteins for the Crohn's disease: A double-blind trial.

Authors:  Eran Israeli; Ehud Zigmond; Gadi Lalazar; Athalia Klein; Nilla Hemed; Eran Goldin; Yaron Ilan
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

6.  Immune therapy for hepatocellular carcinoma.

Authors:  Yaron Ilan
Journal:  Hepatol Int       Date:  2013-12-20       Impact factor: 6.047

7.  A single amino acid defines cross-species reactivity of tree shrew (Tupaia belangeri) CD1d to human invariant natural killer T (iNKT) cells.

Authors:  Ping Zhang; Demin Li; Guillaume Stewart-Jones; Xiaoli Shao; Yuanxu Zhang; Qiongyu Chen; Yijiang Li; You-Wen He; Xiao-Ning Xu; Hua-Tang Zhang
Journal:  Immunology       Date:  2009-06-05       Impact factor: 7.397

8.  Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model.

Authors:  Mengde Cao; Yiling Xu; Je-in Youn; Roniel Cabrera; Xiaokui Zhang; Dmitry Gabrilovich; David R Nelson; Chen Liu
Journal:  Lab Invest       Date:  2011-02-14       Impact factor: 5.662

9.  Fine motor skill training enhances functional plasticity of the corticospinal tract after spinal cord injury.

Authors:  Jian Liu; Xiao-Yu Yang; Wei-Wei Xia; Jian Dong; Mao-Guang Yang; Jian-Hang Jiao
Journal:  Neural Regen Res       Date:  2016-12       Impact factor: 5.135

10.  An immunosuppressive subtype of neutrophils identified in patients with hepatocellular carcinoma.

Authors:  Yasuhiro Tsuda; Hideo Fukui; Akira Asai; Shinya Fukunishi; Katsuhiko Miyaji; Shinya Fujiwara; Kazuhisa Teramura; Akira Fukuda; Kazuhide Higuchi
Journal:  J Clin Biochem Nutr       Date:  2012-10-12       Impact factor: 3.114

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.